Literature DB >> 21443906

Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease.

J M Walker1, S W Fowler, D K Miller, A Y Sun, G A Weisman, W G Wood, G Y Sun, A Simonyi, T R Schachtman.   

Abstract

This study provides an examination of spatial learning and a behavioral assessment of irritability and locomotion in TgCRND8 mice, an amyloid precursor protein transgenic model of Alzheimer's disease. Performance was assessed using the Barnes maze, the touch escape test, and an open-field test. While past research focused primarily on 2-5-month-old TgCRND8 mice, the present study used an older age cohort (9-month-old female mice), in addition to a 4-month-old cohort of both transgenic (Tg) and wildtype female mice. Both younger and older Tg mice displayed poor spatial learning in the Barnes maze task compared to their wildtype littermates, as demonstrated by significantly longer latencies and more errors both during acquisition and at a 2-week retest. No differences in irritability were found between Tg and control mice in the younger cohort; however, older Tg mice displayed significantly higher irritability compared with wildtype littermates, as measured by the touch escape test. Additionally, Tg mice of both age cohorts showed increased locomotion and slowed habituation during a 60-min open-field test over 3 days of testing. These results demonstrate that TgCRND8 mice show significant deficits in spatial and nonspatial behavioral tasks at advanced stages of amyloid pathology.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21443906     DOI: 10.1016/j.bbr.2011.03.049

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  34 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 2.  Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.

Authors:  A Shepherd; S Tyebji; A J Hannan; E L Burrows
Journal:  J Mol Neurosci       Date:  2016-09-16       Impact factor: 3.444

Review 3.  Disease modification in epilepsy: from animal models to clinical applications.

Authors:  Melissa L Barker-Haliski; Dan Friedman; Jacqueline A French; H Steve White
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

4.  A chronic physical activity treatment in obese rats normalizes the contributions of ET-1 and NO to insulin-mediated posterior cerebral artery vasodilation.

Authors:  T Dylan Olver; Matthew W McDonald; Diana Klakotskaia; Rachel A Richardson; Jeffrey L Jasperse; C W James Melling; Todd R Schachtman; Hsiao T Yang; Craig A Emter; M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2017-02-09

5.  Treadmill exercise prevents learning and memory impairment in Alzheimer's disease-like pathology.

Authors:  An T Dao; Munder A Zagaar; Amber T Levine; Samina Salim; Jason L Eriksen; Karim A Alkadhi
Journal:  Curr Alzheimer Res       Date:  2013-06       Impact factor: 3.498

6.  Barnes maze testing strategies with small and large rodent models.

Authors:  Cheryl S Rosenfeld; Sherry A Ferguson
Journal:  J Vis Exp       Date:  2014-02-26       Impact factor: 1.355

7.  Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouse model.

Authors:  Melissa L Barker-Haliski; E Jill Dahle; Taylor D Heck; Timothy H Pruess; Fabiola Vanegas; Karen S Wilcox; H Steve White
Journal:  J Pharmacol Exp Ther       Date:  2015-03-09       Impact factor: 4.030

8.  Disruption of adult expression of sexually selected traits by developmental exposure to bisphenol A.

Authors:  Eldin Jašarević; Paizlee T Sieli; Erin E Twellman; Thomas H Welsh; Todd R Schachtman; R Michael Roberts; David C Geary; Cheryl S Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

9.  Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice.

Authors:  Zu-Lin Chen; Alexey S Revenko; Pradeep Singh; A Robert MacLeod; Erin H Norris; Sidney Strickland
Journal:  Blood       Date:  2017-02-27       Impact factor: 22.113

10.  Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.

Authors:  Y C Chung; A Kruyer; Y Yao; E Feierman; A Richards; S Strickland; E H Norris
Journal:  J Thromb Haemost       Date:  2016-06-13       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.